Menarini Diagnostics acquires EOS Preanalytics and Point Of Care company assets

A.MENARINI DIAGNOSTICS and BIOACTIVA DIAGNOSTICA GMBH SIGN AN EXCLUSIVE AGREEMENT FOR LIOFERON® TB/LTBI, A TEST TO DIAGNOSE LATENT TUBERCULOSIS INFECTION.

September 3rd, 2020 – Firenze, Italy and Bad Homburg, Germany

German Minister of Health Jens Spahn receives briefing on Menarini Diagnostics fast and reliable COVID VitaPCR® POC instrument.

On August 20th the German Minister of Health, Jens Spahn visited the Red Cross Hospital of Mölln-Ratzeburg.

A.Menarini Diagnostics Announces Agreement with Skyla Corporation in the area of Point of Care Testing

Hsinchu, Taiwan and Florence, Italy, July 24th, 2020

1 2 3 4

Our values

10 core values have influenced the progress of our group.

A. Menarini Diagnostics s.r.l - Società con socio unico - Sede della società: Via Sette Santi 3 - 50131 Firenze - Numero di iscrizione registro imprese: 05688870483 - Ufficio del registro delle imprese: Firenze
Capitale: € 30.000.000 I.V. - Capitale risultante dall’ultimo bilancio: € 30.000.000 - Società soggetta all’attività di direzione e coordinamento di A. Menarini Industrie Farmaceutiche Riunite Srl.